Several other research analysts have also recently issued reports on CATS. TheStreet cut Stamps.com from a b- rating to a c+ rating in a research note on Monday, March 11th. Canaccord Genuity decreased their price target on Cronos Group from C$17.00 to C$16.00 in a research note on Friday, May 10th. Finally, Dougherty & Co started coverage on Catasys in a research note on Tuesday, May 7th. They issued a buy rating for the company. One equities research analyst has rated the stock with a sell rating, five have given a buy rating and two have issued a strong buy rating to the stock. The stock presently has a consensus rating of Buy and an average price target of $19.00.
NASDAQ:CATS opened at $19.60 on Tuesday. Catasys has a 1 year low of $6.42 and a 1 year high of $20.83. The stock has a fifty day simple moving average of $18.46.
Catasys (NASDAQ:CATS) last released its quarterly earnings results on Thursday, May 9th. The company reported ($0.18) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.24) by $0.06. The business had revenue of $6.81 million during the quarter, compared to the consensus estimate of $5.64 million. On average, research analysts expect that Catasys will post -0.96 EPS for the current year.
In related news, major shareholder David E. Smith sold 135,773 shares of the firm’s stock in a transaction dated Thursday, April 25th. The stock was sold at an average price of $14.99, for a total transaction of $2,035,237.27. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder David E. Smith sold 164,031 shares of the firm’s stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $16.54, for a total value of $2,713,072.74. The disclosure for this sale can be found here. Insiders have sold 401,811 shares of company stock valued at $6,465,985 in the last ninety days. Company insiders own 60.80% of the company’s stock.
A number of hedge funds have recently made changes to their positions in CATS. Barclays PLC purchased a new stake in shares of Catasys during the fourth quarter valued at $455,000. Janney Montgomery Scott LLC lifted its holdings in shares of Catasys by 19.1% during the first quarter. Janney Montgomery Scott LLC now owns 171,223 shares of the company’s stock valued at $2,094,000 after purchasing an additional 27,467 shares during the last quarter. Kennedy Capital Management Inc. lifted its holdings in shares of Catasys by 7.3% during the first quarter. Kennedy Capital Management Inc. now owns 301,087 shares of the company’s stock valued at $3,682,000 after purchasing an additional 20,469 shares during the last quarter. CIBC Private Wealth Group LLC purchased a new stake in shares of Catasys during the first quarter valued at $187,000. Finally, Westwood Management Corp IL lifted its holdings in shares of Catasys by 37.5% during the first quarter. Westwood Management Corp IL now owns 55,000 shares of the company’s stock valued at $673,000 after purchasing an additional 15,000 shares during the last quarter. 12.66% of the stock is owned by institutional investors and hedge funds.
Catasys Company Profile
Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.
Featured Article: What is meant by buying and selling pressure?
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.